Nonproteinuric Preeclampsia among Women with Hypertensive Disorders of Pregnancy at a Referral Hospital in Southwestern Uganda.
Journal
Obstetrics and gynecology international
ISSN: 1687-9589
Titre abrégé: Obstet Gynecol Int
Pays: United States
ID NLM: 101517078
Informations de publication
Date de publication:
2021
2021
Historique:
received:
20
07
2021
revised:
14
08
2021
accepted:
19
08
2021
entrez:
10
9
2021
pubmed:
11
9
2021
medline:
11
9
2021
Statut:
epublish
Résumé
Preeclampsia is a priority obstetric emergency requiring urgent diagnosis and treatment to avert poor pregnancy outcomes. Nonproteinuric preeclampsia poses even greater diagnostic challenges due to contested diagnostic criteria by the clinical practice guidelines and variable clinical presentation. Previously, preeclampsia was only diagnosed if high blood pressure and proteinuria were present. This study determined the prevalence of nonproteinuric preeclampsia and associated factors among women admitted with hypertensive disorders of pregnancy at a referral hospital in southwestern Uganda. Women with hypertensive disorders of pregnancy were consecutively enrolled in a cross-sectional study at Mbarara Regional Referral Hospital between November 2019 and May 2020. We interviewed all pregnant women ≥20 gestation weeks presenting with hypertension and obtained their sociodemographic, medical, and obstetric characteristics. We excluded women with chronic hypertension. We measured bedside dipstick proteinuria in clean-catch urine. Preeclampsia was defined as hypertension plus any feature of severity including <100,000 platelets/ul, creatinine >1.1 g/dl, and liver transaminases ≥twice upper normal limit with or without proteinuria. We defined nonproteinuric preeclampsia in participants with <+2 urine dipstick cut-off and determined the factors associated with nonproteinuric preeclampsia using logistic regression. We enrolled 134 participants. The mean age was 26.9 (SD ± 7.1) years and 51.5% were primigravid. The prevalence of nonproteinuric preeclampsia was 24.6% (95% CI: 17.9-32.7). Primigravidity (aOR 2.70 95% CI: 1.09-6.72, Nonproteinuric preeclampsia was common, especially among primigravidae. We recommend increased surveillance for nonproteinuric preeclampsia, especially among first-time pregnant women, who may not be detected by the traditional criteria. Obstetrics care providers should emphasize laboratory testing beyond proteinuria, among all women with hypertensive disorders of pregnancy to optimally diagnose and manage nonproteinuric preeclampsia.
Sections du résumé
BACKGROUND
BACKGROUND
Preeclampsia is a priority obstetric emergency requiring urgent diagnosis and treatment to avert poor pregnancy outcomes. Nonproteinuric preeclampsia poses even greater diagnostic challenges due to contested diagnostic criteria by the clinical practice guidelines and variable clinical presentation. Previously, preeclampsia was only diagnosed if high blood pressure and proteinuria were present. This study determined the prevalence of nonproteinuric preeclampsia and associated factors among women admitted with hypertensive disorders of pregnancy at a referral hospital in southwestern Uganda.
METHODS
METHODS
Women with hypertensive disorders of pregnancy were consecutively enrolled in a cross-sectional study at Mbarara Regional Referral Hospital between November 2019 and May 2020. We interviewed all pregnant women ≥20 gestation weeks presenting with hypertension and obtained their sociodemographic, medical, and obstetric characteristics. We excluded women with chronic hypertension. We measured bedside dipstick proteinuria in clean-catch urine. Preeclampsia was defined as hypertension plus any feature of severity including <100,000 platelets/ul, creatinine >1.1 g/dl, and liver transaminases ≥twice upper normal limit with or without proteinuria. We defined nonproteinuric preeclampsia in participants with <+2 urine dipstick cut-off and determined the factors associated with nonproteinuric preeclampsia using logistic regression.
RESULTS
RESULTS
We enrolled 134 participants. The mean age was 26.9 (SD ± 7.1) years and 51.5% were primigravid. The prevalence of nonproteinuric preeclampsia was 24.6% (95% CI: 17.9-32.7). Primigravidity (aOR 2.70 95% CI: 1.09-6.72,
CONCLUSION
CONCLUSIONS
Nonproteinuric preeclampsia was common, especially among primigravidae. We recommend increased surveillance for nonproteinuric preeclampsia, especially among first-time pregnant women, who may not be detected by the traditional criteria. Obstetrics care providers should emphasize laboratory testing beyond proteinuria, among all women with hypertensive disorders of pregnancy to optimally diagnose and manage nonproteinuric preeclampsia.
Identifiants
pubmed: 34504529
doi: 10.1155/2021/9751775
pmc: PMC8423541
doi:
Types de publication
Journal Article
Langues
eng
Pagination
9751775Informations de copyright
Copyright © 2021 Asiphas Owaraganise et al.
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Pan Afr Med J. 2014 Jan 18;17 Suppl 1:7
pubmed: 24643210
BMJ. 2010 Aug 25;341:c2207
pubmed: 20739360
J Hypertens. 2008 Feb;26(2):295-302
pubmed: 18192844
Lancet. 2012 May 5;379(9827):1686-7
pubmed: 22177535
BMJ. 1994 Nov 26;309(6966):1395-400
pubmed: 7819845
Obstet Gynecol. 2010 Feb;115(2 Pt 1):365-375
pubmed: 20093912
PLoS One. 2020 Aug 19;15(8):e0237476
pubmed: 32813709
Best Pract Res Clin Obstet Gynaecol. 2011 Aug;25(4):449-62
pubmed: 21459048
BMC Pregnancy Childbirth. 2016 Aug 04;16:205
pubmed: 27492552
Hypertension. 2019 Apr;73(4):757-766
pubmed: 30686084
Pregnancy Hypertens. 2014 Apr;4(2):97-104
pubmed: 26104417
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Int J Gynaecol Obstet. 2002 Apr;77(1):67-75
pubmed: 12094777
J Pregnancy. 2012;2012:586578
pubmed: 22848831
J Family Med Prim Care. 2015 Apr-Jun;4(2):257-60
pubmed: 25949977
J Obstet Gynaecol Can. 2011 Jun;33(6):588-597
pubmed: 21846448
Best Pract Res Clin Obstet Gynaecol. 2011 Aug;25(4):391-403
pubmed: 21333604
Hypertension. 2018 Jul;72(1):24-43
pubmed: 29899139
Obstet Gynecol. 2013 Nov;122(5):1122-1131
pubmed: 24150027
BMC Pregnancy Childbirth. 2016 Aug 05;16(1):207
pubmed: 27495904
Lancet. 2010 Aug 21;376(9741):631-44
pubmed: 20598363